133 related articles for article (PubMed ID: 20388695)
1. Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis.
Tao K; Qian N; Tang Y; Ti Z; Song W; Cao D; Dou K
Jpn J Clin Oncol; 2010 Jul; 40(7):645-51. PubMed ID: 20388695
[TBL] [Abstract][Full Text] [Related]
2. Fascin expression in progression and prognosis of hepatocellular carcinoma.
Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN
Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
[TBL] [Abstract][Full Text] [Related]
6. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
Hsu YC; Fu HH; Jeng YM; Lee PH; Yang SD
J Clin Oncol; 2006 Aug; 24(23):3780-8. PubMed ID: 16754939
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma.
Yang W; Lv S; Liu X; Liu H; Yang W; Hu F
Jpn J Clin Oncol; 2010 Nov; 40(11):1053-9. PubMed ID: 20522449
[TBL] [Abstract][Full Text] [Related]
10. [Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma].
Zhang B; Zhong DW; Wang QW; Miao XY; Dai WD; Liu C; Pan KH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):368-70, 373. PubMed ID: 20368117
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors.
Kaido T; Oe H; Yoshikawa A; Mori A; Arii S; Imamura M
Hepatogastroenterology; 2005; 52(65):1383-7. PubMed ID: 16201079
[TBL] [Abstract][Full Text] [Related]
13. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
[TBL] [Abstract][Full Text] [Related]
14. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].
Wu LQ; Lu Y; Lu HJ; Zhang B; Yang JY; Ma X
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):774-7. PubMed ID: 16836930
[TBL] [Abstract][Full Text] [Related]
17. Expression of platelet-activating factor receptor: a novel prognosticator in patients with hepatocellular carcinoma following hepatectomy.
Kitagawa D; Taketomi A; Kayashima H; Kuroda Y; Itoh S; Yamashita Y; Maehara Y
Oncology; 2007; 72(5-6):381-7. PubMed ID: 18187960
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T
J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
[TBL] [Abstract][Full Text] [Related]
19. High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma.
Zhang Y; Zha TZ; Hu BS; Jiang C; Ge ZJ; Zhang K; Tan YF
Surgeon; 2013 Apr; 11(2):67-71. PubMed ID: 22878099
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]